Clinical research has demonstrated that GLP-1 medications effectively support metabolic health in women across all reproductive stages, including premenopausal, perimenopausal, and postmenopausal women
People on semaglutide consistently report feeling less hungry, less preoccupied with food, and more satisfied with smaller portions
Allowing the medication to reach room temperature before injection reduces the sting
Nello studio SURMOUNT-5, lunico trial testa a testa disponibile tra i due farmaci, semaglutide alla dose standard di 1,7 o 2,4 mg ha prodotto una perdita di peso del 13,7%, contro il 20,2% del tirzepatide 10 o 15 mg (Aronne et al., 2025)
I wasnt stressed, lost weight, or have any health issues